Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 220381
Company: FRESENIUS KABI USA LLC

Products on NDA 220381

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
GLYCOPHOS	SODIUM GLYCEROPHOSPHATE	1MMOL/ML	INJECTABLE;INJECTION	Prescription	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 220381

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/29/2026	ORIG-1	Approval	Type 2 - New Active Ingredient	STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/220381Orig1s000ltr.pdf